Stock NLSP NLS PHARMACEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.125 USD -3.99% Intraday chart for NLS Pharmaceutics Ltd. -6.02% -78.81%
Apr. 08 Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors CI
Apr. 03 NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding CI

Business Summary

NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.

Managers

Managers TitleAgeSince
Eric Konofal FOU
 Founder 57 15-06-09
Alexander Zwyer FOU
 Founder 54 15-06-09
Elena Thyen-Pighin DFI
 Director of Finance/CFO - 23-05-19
George Apostol CTO
 Chief Tech/Sci/R&D Officer 51 22-09-07
David Moskowitz IRC
 Investor Relations Contact - -
Hervé Girsault PRN
 Corporate Officer/Principal 64 16-08-31

Members of the board

Members of the board TitleAgeSince
Audrey Greenberg BRD
 Director/Board Member 51 23-06-29
Alexander Zwyer FOU
 Founder 54 15-06-09
Ronald Hafner FOU
 Founder 60 15-06-09
Gian-Marco Rinaldi Diaz de la Cruz BRD
 Director/Board Member 55 21-06-16
Anthony Walsh BRD
 Director/Board Member - 23-06-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 42,806,136 27,083,431 ( 63.27 %) 3,242,887 ( 7.576 %) 63.27 %

Shareholders

NameEquities%Valuation
BVF, Inc.
16.11 %
5,747,126 16.11 % 1 M $
Yorkville Advisors Global LP
11.10 %
3,959,128 11.10 % 712 643 $
The Lind Partners LLC
9.812 %
3,500,000 9.812 % 630 000 $
Felix Grisard
9.091 %
3,242,889 9.091 % 583 720 $
Magnetic Rock Investment AG
7.975 %
2,845,000 7.975 % 512 100 $
Ronald Hafner
6.727 %
2,399,491 6.727 % 431 908 $
Alexander Zwyer
3.998 %
1,426,066 3.998 % 256 692 $
George Apostol
3.641 %
1,298,701 3.641 % 233 766 $
Eric Konofal
2.873 %
1,025,000 2.873 % 184 500 $
Gian-Marco Rinaldi Diaz de la Cruz
0.4549 %
162,259 0.4549 % 29 207 $
NameEquities%Valuation
Armistice Capital LLC
-
500,000 - 24 500 $
Altium Capital Management LP
-
200,000 - 9 800 $
Ayrton Capital LLC
-
170,100 - 8 335 $
Hudson Bay Capital Management LP
-
100,000 - 4 900 $
Clear Street LLC
-
8,500 - 417 $
UBS Securities LLC
-
1,000 - 49 $

Company contact information

NLS Pharmaceutics Ltd.

The Circle 6

8058, Zurich

+

http://www.nlspharma.com
address NLS Pharmaceutics Ltd.(NLSP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
NLS PHARMACEUTICS LTD. Stock NLS Pharmaceutics Ltd.
-78.81% 5.89M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+4.09% 43.84B
LONZA GROUP AG Stock Lonza Group AG
+46.96% 41.25B
MODERNA, INC. Stock Moderna, Inc.
+9.45% 41.68B
CELLTRION, INC. Stock Celltrion, Inc.
-10.92% 27.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.32% 25.53B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.87% 18.18B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.70% 12.29B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
+1.28% 12.29B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.78% 11.15B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. Company NLS Pharmaceutics Ltd.